Neurofibromatosis tipo 1 y trastorno por déficit de atención. Nuestra experiencia actual

Sánchez-Marco, Silvia B; López-Pisón, Javier; Serrano-Viñuales, Itziar; Troyas-Fernández de Garayalde, Leire; Lafuente-Hidalgo, Miguel; Monge-Galindo, Lorena.
Rev. neurol. (Ed. impr.) ; 68(1): 7-10, 1 ene., 2019. tab
Artículo en Español | IBECS (España) | ID: ibc-175204

Documentos relacionados

  1. Neurofibromatosis type 1 system-based manifestations and treatments: a review.
  2. Bone Mineral Density in Neurofibromatosis Type 1: A Systematic Review and Meta-Analysis.
  3. Role, function and challenges of multidisciplinary centres for rare diseases exemplified for neurofibromatosis type 1 syndrome.
  4. Segmental spinal neurofibromatosis 1: a novel phenotype.
  5. Survival outcomes of malignant peripheral nerve sheath tumors (MPNSTs) with and without neurofibromatosis type I (NF1): a meta-analysis.
  6. Consensus-Based Best Practice Guidelines for the Management of Spinal Deformity and Associated Tumors in Pediatric Neurofibromatosis Type 1: Screening and Surveillance, Surgical Intervention, and Medical Therapy.
  7. Clinical presentation and genetic analyses of neurofibromatosis type 1 in independent patients with monoallelic double de novo closely spaced mutations in the NF1 gene.
  8. Contribution of whole genome sequencing in the molecular diagnosis of mosaic partial deletion of the NF1 gene in neurofibromatosis type 1.
  9. How do people with neurofibromatosis type 1 (the forgotten victims) live? A grounded theory study.
  10. The skeletal muscle phenotype of children with Neurofibromatosis Type 1 - A clinical perspective.